| | | | | | | | With recent policy changes, such as the executive order on lowering prescription drug costs which currently impacts Medicare and Medicaid, forward-thinking executives are rightfully contemplating the potential extension of these measures to all drugs. The question echoes: How can pharma leaders not only navigate these changes but proactively position their organizations for success? |
|
|
|
| |
| | |
|
|
| | | | | Novartis could shell out up to $2.7 billion in a quest to expand its radioligand pipeline. |
|
|
| Tivdak, originally developed by Genmab and Seagen, is the first ADC with demonstrated overall survival data to be granted full FDA approval in this patient population. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers have discovered, enhanced quality processes can also unlock significant performance improvements.But quality improvements... |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
